CS1 Administration

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
86	肺動脈性肺高血圧症	1

86. 肺動脈性肺高血圧症

臨床試験数 : 1,205 / 薬物数 : 684 - (DrugBank : 124) / 標的遺伝子数 : 100 - 標的パスウェイ数 : 193

trials per page:

Showing 1 to 1 of 1 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05224531 (ClinicalTrials.gov)	May 5, 2022	17/1/2022	Effect of CS1 in Subjects With Pulmonary Arterial Hypertension	A Phase 2, Prospective, Randomized, Open-label, Blinded Endpoint, Multicenter Study to Investigate t ...	Pulmonary Arterial Hypertension	Drug: CS1 Administration	Cereno Scientific AB	Worldwide Clinical Trials	Recruiting	18 Years	80 Years	All	30	Phase 2	Sweden

First Previous1Next Last